MDxHealth Announces Positive Data from Pan-European Clinical Validation Study of SelectMDx

Author's Avatar
Mar 18, 2019
Article's Main Image

SelectMDx demonstrates accurate identification of both low-risk and aggressive prostate cancer across all patient groups

PR Newswire